Universe Pharmaceuticals, Inc. (UPC)
| Market Cap | 67.83M |
| Revenue (ttm) | 30.70M |
| Net Income (ttm) | 7.56M |
| Shares Out | 21.00M |
| EPS (ttm) | 0.36 |
| PE Ratio | 8.97 |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | May 12 |
| Last Price | $3.23 |
| Previous Close | $3.30 |
| Change ($) | -0.07 |
| Change (%) | -2.12% |
| Day's Open | 3.33 |
| Day's Range | 3.22 - 3.48 |
| Day's Volume | 167,257 |
| 52-Week Range | 3.02 - 11.99 |
Here's why UPC stock is surging today on news that a broker leading the deal exercised its over-allotment option, in a surprising move. The post UPC Stock: Why Universe Pharmaceuticals Is Popping Higher...
Ji'an, Jiangxi, China, March 31, 2021 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced the underwriter ...
Shares of several penny stocks are on the rise today as Reddit investors continue to pick out the top ones to take a risk on. The post Top Penny Stocks Today: What to Know About BAYP, SEAC, UPC, CPHI, C...
Universe Pharmaceuticals (UPC) stock is soaring higher in early trading Monday morning despite a lack of news concerning the Chinese company. The post UPC Stock: 10 Things to Know as Universe Pharmaceut...
Ji'an, Jiangxi, China, March 25, 2021 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced the closing of i...
Ji'an, Jiangxi, China, March 23, 2021 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”), a pharmaceutical producer and distributor in China, today announced the pricing of its initial pub...
About UPC
Universe Pharmaceuticals is a pharmaceutical company based in Jiangxi, China, specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives (“TCMD”) products targeting the elderly with the goal of addressing their physical conditions in the aging process and to promote their general well-being. We have registered and obtained approval for 26 varieties of TCMD products from the National Medical Products Administration (the “NMPA”), and we currently produce 13 varieties of TCMD products, ... [Read more...]
| Industry Medicinal and Botanical Manufacturing | IPO Date Mar 23, 2021 |
| CEO Gang Lai | Employees 176 |
| Stock Exchange NASDAQ | Ticker Symbol UPC |
Financial Performance
In 2020, UPC's revenue was $30.70 million, a decrease of -7.60% compared to the previous year's $33.23 million. Earnings were $7.56 million, an increase of 0.09%.